According to Stratistics MRC, the Global Blood Culture Test market is expected to grow from $3.01 billion in 2016 to reach $5.65 billion by 2023 with a CAGR of 9.4%. Rising new product launches & number of regulatory approvals, increasing sepsis cases, increasing incidence of bloodstream infections, growing R&D investments for development of the novel testing products and turning demand for rapid diagnostic techniques are some of the factors boosting the market growth. In addition, growing geriatric population and high predominance of infectious diseases are the other key factors promoting the market growth. However, shortage of trained laboratory technicians and huge price of automated instruments are hindering the market growth.

Based on the technologies, molecular technologies segment is expected to grow with a high CAGR during in the forecast period. Molecular technologies have a significant growth due to the factors such as rising incidence of sepsis that calls for speedy diagnostic techniques for finding the presence of mycobacteria, fungi and bacteria from blood samples. By end users, reference laboratories segment is expected to grow at the highest CAGR in the forecast period. Reference Laboratories are the developing source of blood culture tests in hospitals. They are outfitted with advanced diagnostic techniques that offer blood culture tests with a quick turnaround time.

North America represents as the largest market in terms of revenue due to the local existence of multinational healthcare companies like BioMérieux SA, Roche Diagnostics, Dickinson & Company and Becton. Asia Pacific is expected to witness a brisk market growth over the forecast period. Circumstances like government actions to raise realization on the disease in public and rising awareness about early disease diagnosis are the major factors for the market growth in this region.

Some of the key players in global blood culture test market include Becton, Dickinson and Company, Alere Inc., Thermo Fisher Scientific, Inc., Cepheid, Nanosphere, Inc., Bruker Corporation, Beckman Coulter, Roche Diagnostics, Iridica, T2 Biosystems, Siemens, Nanosphere Inc., BioMerieux SA and Luminex Corporation.

Applications Covered:
• Mycobacterial Detection
• Bacteremia
• Fungemia

Technologies Covered:
• Proteomics Technology
• Culture-Based Technology
• Molecular Technologies

Methods Covered:
• Automated Methods
• Conventional/Manual Methods

Products Covered:
• Software and Services
• Instruments
• Consumables

End Users Covered:
• Academic Research Laboratories
• Hospital Laboratories
• Reference Laboratories
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements